A clinical case of successful application of a new treatment method for severe COVID-19
Alexander S. Samoylov , Yuri D. Udalov , Nikolai M. Kruglyakov , Dmitry А. Terekhov , German I. Bagzhanov , Sergey S. Ochkin
Journal of Clinical Practice ›› 2020, Vol. 11 ›› Issue (2) : 93 -100.
A clinical case of successful application of a new treatment method for severe COVID-19
COVID-19, formerly coronavirus infection 2019-nCoV, is a potentially severe acute respiratory infection caused by the SARS-CoV-2 coronavirus (2019-nCoV). It is a dangerous disease that can occur both in the form of a mild acute respiratory viral infection and in a severe form with the development of bilateral polysegmental viral pneumonia, specific complications of which may include acute respiratory distress syndrome, resulting in the respiratory failure with a high risk of death. Due to the absence of etiotropic therapy for the coronavirus infection, pathogentic treatment becomes of primary importance. We present a clinical case of a severe form of COVID-19 in a 33-year-old man to whom we administered a new method of pathogenetic treatment of this disease based on immunosuppresiive therapy followed by therapeutic plasma exchange and infusion of non-specific human immunoglobulin.
COVID-19 / selective plasma filtration / immunosuppression / plasma exchange / case report
Samoylov A.S., Udalov Y.D., Kruglyakov N.M., Terekhov D.А., Bagzhanov G.I., Ochkin S.S.
/
| 〈 |
|
〉 |
PDF
